pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 6·1 min read
save

CDC appoints Erica Schwartz as director and Moderna secures approval for mRNA flu vaccine

Aug 6, 2026·read at STAT ↗RegulatoryNeutral

The U.S. Centers for Disease Control and Prevention announced that Erica Schwartz has been confirmed as its director, filling a vacancy that has lasted nearly a year.

In a separate regulatory update, the Food and Drug Administration granted approval to Moderna's mRNA-based influenza vaccine, marking the first mRNA flu shot to receive clearance.

The newsletter also highlighted ongoing public health challenges, including measles cases, a food-borne parasite outbreak, and a large Ebola cluster in Africa, underscoring the agency's broader workload.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Covid can reactivate dormant viruses, according to study”

read at STAT ↗
1,025 words · retrieved Aug 6
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Moderna, Inc.6BARRUltragenyx Pharmaceutical Inc.University of Pennsylvania
drugs
influenza vaccine2
topics
mRNA Therapeutic6Vaccine5Infectious Disease2Psychiatry & CNS2ApprovalDuchenne Muscular DystrophyMicrobiomeRare Disease

related stories

  • Aug 6FDA approves Moderna’s mRNA flu vaccine, the first to use the technologySTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 4d agoSionna says good-bye to 46% of staffers, including execBioSpace
  • 6d agoAfter a brief storm of political headwinds, mRNA is back with strong momentumBioSpace
  • Sep 1GSK to launch Phase 3 trial for mRNA-based flu vaccine amid resurgence for the modalityBioSpace